Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 201...
Published in: | European Journal of Obstetrics & Gynecology and Reproductive Biology |
---|---|
Main Authors: | , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10037/28519 https://doi.org/10.1016/j.ejogrb.2022.11.019 |
id |
ftunivtroemsoe:oai:munin.uit.no:10037/28519 |
---|---|
record_format |
openpolar |
spelling |
ftunivtroemsoe:oai:munin.uit.no:10037/28519 2023-05-15T18:34:21+02:00 Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw Bjørkås, Merethe Skjeldestad, Finn Egil 2022-11-23 https://hdl.handle.net/10037/28519 https://doi.org/10.1016/j.ejogrb.2022.11.019 eng eng Elsevier European Journal of Obstetrics, Gynecology, and Reproductive Biology Bjørkås, Skjeldestad. Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2022 FRIDAID 2113371 doi:10.1016/j.ejogrb.2022.11.019 0301-2115 1872-7654 https://hdl.handle.net/10037/28519 Attribution 4.0 International (CC BY 4.0) openAccess Copyright 2022 The Author(s) https://creativecommons.org/licenses/by/4.0 CC-BY Journal article Tidsskriftartikkel Peer reviewed acceptedVersion 2022 ftunivtroemsoe https://doi.org/10.1016/j.ejogrb.2022.11.019 2023-02-09T00:03:55Z Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 2015–16 Tromsø Study, which collected self-reported sociodemographic information and data from a wide range of validated health questionnaires. The participants had been sexually active the last 12 months prior enrollment, were not pregnant, not trying to conceive, and had no prior fertility problems. We categorized use of HC into three groups; no HC use, hormonal IUD use and other HC use. Explanatory variables included demographic, educational, economic and general health variables. All analyses were performed in SPSS with chi-square test and logistic regression at significance level p < 0.05. Results - Nearly 50 % of the study sample reported HC use with hormonal IUD use as the major method (39.5 %/40–44 years; 43.4 %/45–49 years old women). There were no differences in HC use by partner status, educational level, or BMI. Though statistically significant, we found only minor differences in HC use by occupational status, gross household income, and general health status, with higher proportions of women with no paid work, the lowest income, and poor health status reporting no HC use. Conclusion - The high HC use and the minor differences found across demographic and socioeconomic parameters indicate that HC use, and hormonal IUD use in particular, is widely used among middle-aged women living in the city of Tromsø. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Norway Tromsø European Journal of Obstetrics & Gynecology and Reproductive Biology 280 93 97 |
institution |
Open Polar |
collection |
University of Tromsø: Munin Open Research Archive |
op_collection_id |
ftunivtroemsoe |
language |
English |
description |
Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 2015–16 Tromsø Study, which collected self-reported sociodemographic information and data from a wide range of validated health questionnaires. The participants had been sexually active the last 12 months prior enrollment, were not pregnant, not trying to conceive, and had no prior fertility problems. We categorized use of HC into three groups; no HC use, hormonal IUD use and other HC use. Explanatory variables included demographic, educational, economic and general health variables. All analyses were performed in SPSS with chi-square test and logistic regression at significance level p < 0.05. Results - Nearly 50 % of the study sample reported HC use with hormonal IUD use as the major method (39.5 %/40–44 years; 43.4 %/45–49 years old women). There were no differences in HC use by partner status, educational level, or BMI. Though statistically significant, we found only minor differences in HC use by occupational status, gross household income, and general health status, with higher proportions of women with no paid work, the lowest income, and poor health status reporting no HC use. Conclusion - The high HC use and the minor differences found across demographic and socioeconomic parameters indicate that HC use, and hormonal IUD use in particular, is widely used among middle-aged women living in the city of Tromsø. |
format |
Article in Journal/Newspaper |
author |
Bjørkås, Merethe Skjeldestad, Finn Egil |
spellingShingle |
Bjørkås, Merethe Skjeldestad, Finn Egil Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
author_facet |
Bjørkås, Merethe Skjeldestad, Finn Egil |
author_sort |
Bjørkås, Merethe |
title |
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
title_short |
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
title_full |
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
title_fullStr |
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
title_full_unstemmed |
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw |
title_sort |
hormonal iud is the major hormonal contraceptive method used among women aged 40 –49 years: data from the 2015 –16 tromsø study, norw |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://hdl.handle.net/10037/28519 https://doi.org/10.1016/j.ejogrb.2022.11.019 |
geographic |
Norway Tromsø |
geographic_facet |
Norway Tromsø |
genre |
Tromsø |
genre_facet |
Tromsø |
op_relation |
European Journal of Obstetrics, Gynecology, and Reproductive Biology Bjørkås, Skjeldestad. Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2022 FRIDAID 2113371 doi:10.1016/j.ejogrb.2022.11.019 0301-2115 1872-7654 https://hdl.handle.net/10037/28519 |
op_rights |
Attribution 4.0 International (CC BY 4.0) openAccess Copyright 2022 The Author(s) https://creativecommons.org/licenses/by/4.0 |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.1016/j.ejogrb.2022.11.019 |
container_title |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
container_volume |
280 |
container_start_page |
93 |
op_container_end_page |
97 |
_version_ |
1766219051708710912 |